EVQLV
Accelerating the speed that healing reaches those in need
- Headquarters
- Woodside, New York
- Founded
- 2020
- Website
- evqlv.com
- Total Funding
- $3.4M
- Last Round
- $500K AngelOct 2024
About
EVQLV is an AI-driven biotechnology company that leverages machine learning and computational biology to accelerate the discovery and development of therapeutic antibodies. Its HyperBind2 platform enables multi-shot learning for progressive antibody optimization, and its Abtique product makes AI-powered antibody discovery accessible to pharma and biotech partners at the discovery stage.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account